1109. A multicenter, observational study to compare the effectiveness of Ceftazidime-Avibactam versus Ceftolozane-Tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the United States (CACTUS)

BACKGROUND: Ceftolozane-tazobactam (CT) and ceftazidime-avibactam (CZA) are front-line agents for treatment of multidrug-resistant (MDR) Pseudomonas aeruginosa; however, real-world comparative-effectiveness data are lacking. METHODS: CACTUS is a retrospective, matched, multicenter study to compare t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shields, Ryan K, Abbo, Lilian M, Ackley, Renee, Aitken, Samuel L, Albrecht, Benjamin, Babiker, Ahmed, Cifuentes, Renzo, Claeys, Kimberly C, DeSear, Kathryn, Gallagher, Jason C, Gregory, Eric, Heil, Emily L, Hickey, Carissa, Klatt, Megan, Kline, Ellen G, Kubat, Ryan C, Kufel, Wesley D, Hyoung Lee, Jae, Lim, Ahmi, Lingg, Theresa, MacDougall, Conan, Mathers, Amy, McCreary, Erin K, Moore, William J, Olson, Shannon, Oxer, Jessica, Pearson, Jeffrey C, Pham, Christine, Polk, Christopher, Satlin, Michael J, Satola, Sarah W, Shah, Sunish, Solanki, Yash B, Tamma, Pranita, Vega, Ana, Veena, Venugopalan, Veve, Michael, Wangchinda, Walaiporn, Witt, Lucy S, Wu, Janet, Pogue, jason M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678759/
http://dx.doi.org/10.1093/ofid/ofad500.082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678759/
http://dx.doi.org/10.1093/ofid/ofad500.082

Ejemplares similares